tiprankstipranks
Trending News
More News >
Tetralogic Pharma (TLOG)
OTHER OTC:TLOG
US Market

Tetralogic Pharma (TLOG) Income Statement

Compare
22 Followers

Tetralogic Pharma Income Statement

Last quarter (Q3 2016), Tetralogic Pharma's total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Tetralogic Pharma's net income was $-8.63M. See Tetralogic Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 0.00$ 0.00$ 0.00$ 0.00
Depreciation and Amortization
$ 228.49K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income
$ 0.00$ 0.00$ 0.00$ 0.00
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00
Pretax Income
$ 0.00$ 0.00$ 0.00$ 0.00
Net Income
$ 0.00$ 0.00$ 0.00$ 0.00
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
0.00 0.00 0.00 0.00
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 0.00 0.00
Currency in USD

Tetralogic Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis